Christopher Bakewell
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Christopher Bakewell has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Akshay Batra
Department of Paediatric Gastroenterology, University Hospital Southampton NHS Foundation Trust, Southampton, UK
1 shared publicationAstor Rodrigues
Paediatric Gastroenterology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK
1 shared publicationBhumita Vadgama
Department of Cellular Pathology, University Hospital Southampton NHS Foundation Trust, Southampton, UK
1 shared publication- Geetha Anand
Department of Paediatrics, Oxford University Hospitals NHS Foundation Trust, Oxford, UK
1 shared publication Girish L Gupte
Liver Unit (including Small Bowel Transplantation), Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK
1 shared publication- James John Ashton
Human Genetics and Genomic medicine University of Southampton Southampton UK
1 shared publication
Latest Publications
- 28 October 2025
- Published by BMJ in Frontline Gastroenterology
Practical interpretation of pH impedance in infants and young children
Multichannel intraluminal impedance with pH (MII pH) is increasingly used in children and adults for investigating gastro-oesophageal reflux disease and associated symptoms, but the indications in paediatrics are expanding. Adults’ normal values are obtained from healthy volunteers; however, paediatric values are mostly extrapolated and supported by expert consensus. Some aspects of performing and interpreting MII pH are peculiar to paediatric practice, such as the reliance on liquid and purée feed in infants and children with neurodisability, proxy symptom reporting from guardians and the increasing use of MII pH in children with enteral feeding tubes. In these settings, manual analysis with careful inspection of meal time is encouraged. General anaesthesia may impact the validity and quality of the study and clinicians should weigh this risk against the benefit of inserting the catheter under anaesthesia. A preprocedure preparatory discussion to identify any potential child and/or procedure-specific challenges is considered a good practice to improve the technical success.
- 28 October 2025
- Published by BMJ in Frontline Gastroenterology
Practical interpretation of pH impedance in infants and young children
Multichannel intraluminal impedance with pH (MII pH) is increasingly used in children and adults for investigating gastro-oesophageal reflux disease and associated symptoms, but the indications in paediatrics are expanding. Adults’ normal values are obtained from healthy volunteers; however, paediatric values are mostly extrapolated and supported by expert consensus. Some aspects of performing and interpreting MII pH are peculiar to paediatric practice, such as the reliance on liquid and purée feed in infants and children with neurodisability, proxy symptom reporting from guardians and the increasing use of MII pH in children with enteral feeding tubes. In these settings, manual analysis with careful inspection of meal time is encouraged. General anaesthesia may impact the validity and quality of the study and clinicians should weigh this risk against the benefit of inserting the catheter under anaesthesia. A preprocedure preparatory discussion to identify any potential child and/or procedure-specific challenges is considered a good practice to improve the technical success.
- 12 May 2025
- Published by BMJ in Archives of Disease in Childhood
Prevalence and clinical characteristics of children with coexisting coeliac disease and inflammatory bowel disease
Objective Growing evidence suggests that coeliac disease (CeD) is more common in patients with inflammatory bowel disease (IBD) but diagnostic confusion remains due to overlapping histological and clinical features. Few studies have investigated this relationship in children. We aimed to assess the prevalence of CeD in our paediatric IBD cohort and define the characteristics of IBD when CeD coexists. Methods We conducted a retrospective study of all patients Results 18 of the 479 children with IBD were also diagnosed with CeD (3.75%). 14 underwent duodenal biopsy on gluten, with 13 fulfilling Marsh classification 2–3. Eight children had Crohn’s disease, five had ulcerative colitis and five had IBD-unclassified. 16 out of 18 demonstrated colonic disease; 11 out of 18 had pancolitis. There was no significant difference in the rate of biological therapy use between the IBD-CeD and non-coeliac groups (50% vs 68%). No patients with IBD-CeD underwent IBD surgery. Conclusions 1 in 25 children with IBD had coexisting CeD. Pancolitis was the most prominent IBD phenotype but a diagnosis of CeD was not associated with increased escalation to biological therapy, and no patients required surgery. These findings help to describe the paediatric IBD-coeliac phenotype and demonstrate the importance of considering IBD in children with refractory CeD and screening for CeD in children presenting with IBD.
- 12 May 2025
- Published by BMJ in Archives of Disease in Childhood
Prevalence and clinical characteristics of children with coexisting coeliac disease and inflammatory bowel disease
Objective Growing evidence suggests that coeliac disease (CeD) is more common in patients with inflammatory bowel disease (IBD) but diagnostic confusion remains due to overlapping histological and clinical features. Few studies have investigated this relationship in children. We aimed to assess the prevalence of CeD in our paediatric IBD cohort and define the characteristics of IBD when CeD coexists. Methods We conducted a retrospective study of all patients Results 18 of the 479 children with IBD were also diagnosed with CeD (3.75%). 14 underwent duodenal biopsy on gluten, with 13 fulfilling Marsh classification 2–3. Eight children had Crohn’s disease, five had ulcerative colitis and five had IBD-unclassified. 16 out of 18 demonstrated colonic disease; 11 out of 18 had pancolitis. There was no significant difference in the rate of biological therapy use between the IBD-CeD and non-coeliac groups (50% vs 68%). No patients with IBD-CeD underwent IBD surgery. Conclusions 1 in 25 children with IBD had coexisting CeD. Pancolitis was the most prominent IBD phenotype but a diagnosis of CeD was not associated with increased escalation to biological therapy, and no patients required surgery. These findings help to describe the paediatric IBD-coeliac phenotype and demonstrate the importance of considering IBD in children with refractory CeD and screening for CeD in children presenting with IBD.
- 14 May 2021
- Published by BMJ in Frontline Gastroenterology
- Vol. 13 (2) , 175-177
Autoimmune hepatitis and acquired partial lipodystrophy
The lipodystrophies are an extremely rare group of metabolic conditions which are categorised based on their pathogenesis and phenotype. While primarily known for the striking loss of subcutaneous adipose tissue which they induce, they may also be associated with significant liver injury. In most cases, this results from the secondary deposition of lipid within hepatic parenchyma and is seen predominantly in generalised lipodystrophy. More rarely, patients may develop autoimmune hepatitis. We report a rare case of a 17-month-old boy who developed features of acquired partial lipodystrophy in association with anti-LKM1-positive autoimmune hepatitis following initial presentation with a Henoch-Schönlein purpura-like illness. We describe his challenging path to diagnosis and discuss his ongoing management in an effort to further our understanding of this rare but significant association. This report highlights the need for close clinical observation and a high index of suspicion for recognising early features of lipodystrophy.
- 14 May 2021
- Published by BMJ in Frontline Gastroenterology
- Vol. 13 (2) , 175-177
Autoimmune hepatitis and acquired partial lipodystrophy
The lipodystrophies are an extremely rare group of metabolic conditions which are categorised based on their pathogenesis and phenotype. While primarily known for the striking loss of subcutaneous adipose tissue which they induce, they may also be associated with significant liver injury. In most cases, this results from the secondary deposition of lipid within hepatic parenchyma and is seen predominantly in generalised lipodystrophy. More rarely, patients may develop autoimmune hepatitis. We report a rare case of a 17-month-old boy who developed features of acquired partial lipodystrophy in association with anti-LKM1-positive autoimmune hepatitis following initial presentation with a Henoch-Schönlein purpura-like illness. We describe his challenging path to diagnosis and discuss his ongoing management in an effort to further our understanding of this rare but significant association. This report highlights the need for close clinical observation and a high index of suspicion for recognising early features of lipodystrophy.